Workup for Elevated Alkaline Phosphatase
The first step in evaluating elevated alkaline phosphatase (ALP) should be to confirm its hepatobiliary origin by measuring gamma-glutamyl transferase (GGT) and/or performing alkaline phosphatase isoenzyme fractionation. 1
Step 1: Confirm Source of Elevated ALP
- Measure GGT and/or perform ALP isoenzyme fractionation to determine if the elevated ALP is of hepatobiliary origin 1
- Consider 5'-nucleotidase testing as an alternative marker of hepatobiliary origin 2, 1
- ALP can originate from liver, bone, intestine, or other tissues, so determining the source is critical for appropriate workup 3, 4
Step 2: Initial Clinical Assessment and Laboratory Testing
- Review medication history for potential drug-induced causes of ALP elevation 2, 1
- Obtain additional liver function tests including:
Step 3: Imaging Studies
- Abdominal ultrasound should be performed as the initial imaging study to evaluate for biliary obstruction and parenchymal liver disease 1
- For patients with malignant renal masses, elevated ALP warrants bone scan evaluation due to increased risk of metastatic disease (approximately 10% when ALP is elevated) 2
- In patients with breast cancer, abdominal imaging using diagnostic CT or MRI is indicated with elevated ALP 2
Step 4: Disease-Specific Workup
If hepatobiliary origin is confirmed:
If bone origin is suspected:
If malignancy is suspected:
Important Clinical Considerations
- Extremely high ALP levels (>1000 U/L) are most frequently associated with sepsis, malignant biliary obstruction, and AIDS 5
- Patients with sepsis can present with markedly elevated ALP despite normal bilirubin levels 5
- Benign familial hyperphosphatasemia is a rare cause of elevated ALP that should be considered when other causes are excluded 3
- For oncology patients, ALP should be monitored before each treatment cycle or at least monthly 2
- In patients with renal cell carcinoma, elevated ALP is a significant predictor of bone metastases and should prompt bone scan evaluation 2